These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8846148)

  • 1. Management of an acute hemorrhagic ovarian cyst in a female patient with hemophilia A.
    O'Brien PM; DiMichele DM; Walterhouse DO
    J Pediatr Hematol Oncol; 1996 May; 18(2):233-6. PubMed ID: 8846148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful endoscopic sphincterotomy for choledocholithiasis in a patient with severe hemophilia A and inhibitors.
    Sugiura R; Kuwatani M; Kawakubo K; Sano I; Kato S; Endo T; Sakamoto N
    Clin J Gastroenterol; 2018 Jun; 11(3):188-192. PubMed ID: 29396835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydatid cyst surgery complicated by hemorrhage resistant to activated recombinant factor VII, in a hemophiliac A patient with an inhibitor.
    Nabil S; Bentalha A; Jaiteh L; El Khorassani M; El Koraichi A; El Kettani SE
    Blood Coagul Fibrinolysis; 2016 Sep; 27(6):724-6. PubMed ID: 26761579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of patients with hemophilia A and inhibitors to factor FVIII with cimetidine.
    Ambriz Fernandez R; Quintana Gonzalez S; Martinez Murillo C; Dominguez Garcia V; Rodriguez Moyado H; Collazo Jaloma J
    Arch Med Res; 1996; 27(1):15-8. PubMed ID: 8867361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor VIII-Mimetic Function of Humanized Bispecific Antibody in Hemophilia A.
    Shima M; Hanabusa H; Taki M; Matsushita T; Sato T; Fukutake K; Fukazawa N; Yoneyama K; Yoshida H; Nogami K
    N Engl J Med; 2016 May; 374(21):2044-53. PubMed ID: 27223146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of secondary prophylaxis in children with severe hemophilia.
    Manco-Johnson MJ; Nuss R; Geraghty S; Funk S; Kilcoyne R
    Am J Hematol; 1994 Oct; 47(2):113-7. PubMed ID: 8092125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical complications in a hemophilia patient with factor VIII inhibitor and their endovascular management.
    Sadat U; Naik J; Hayes PD
    Vasc Endovascular Surg; 2008; 42(2):168-72. PubMed ID: 18421033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemophilia with factor VIII and factor IX inhibitors, incidence, bleeding problems and management.
    Mahasandana C; Patharathienskul D; Suvatte V
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():106-12. PubMed ID: 7886549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous hematomyelia in a child with hemophilia A: a case report.
    Aulakh R; Panigrahi I; Naranje K; Sharda S; Marwaha RK
    J Pediatr Hematol Oncol; 2009 Oct; 31(10):766-7. PubMed ID: 19755922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful medical management of a neonate with spontaneous splenic rupture and severe hemophilia A.
    Badawy SM; Rossoff J; Yallapragada S; Liem RI; Sharathkumar AA
    Hematol Oncol Stem Cell Ther; 2017 Mar; 10(1):29-32. PubMed ID: 27178624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinal surgery complicated by a spontaneously acquired factor VIII inhibitor.
    Priluck IA; Howe RB; Eifrig DE; Edson JR; Miller K
    Am J Ophthalmol; 1978 Jul; 86(1):27-30. PubMed ID: 677229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemorrhagic diathesis from transiently acquired Factor VIII complex deficiency.
    Muntean W
    J Pediatr; 1981 Feb; 98(2):262-4. PubMed ID: 6780674
    [No Abstract]   [Full Text] [Related]  

  • 13. Immune tolerance therapy in patients with acquired hemophilia.
    von Depka M
    Hematology; 2004 Aug; 9(4):245-57. PubMed ID: 15621732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquired factor VIII inhibitor (acquired hemophilia A) presenting as spontaneous blood-filled scrotum.
    Verma R; Noack J; Vemuri R; Loehrke ME
    South Med J; 2011 May; 104(5):368-70. PubMed ID: 21606723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A United Kingdom Haemophilia Centre Doctors' Organization guideline approved by the British Committee for Standards in Haematology: guideline on the use of prophylactic factor VIII concentrate in children and adults with severe haemophilia A.
    Richards M; Williams M; Chalmers E; Liesner R; Collins P; Vidler V; Hanley J;
    Br J Haematol; 2010 May; 149(4):498-507. PubMed ID: 20230411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current issues in prophylactic therapy for persons with hemophilia.
    Dunn AL; Abshire TC
    Acta Haematol; 2006; 115(3-4):162-71. PubMed ID: 16549891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New therapies for hemophilia.
    Pipe SW
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):650-656. PubMed ID: 27913542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and course of inhibitors among patients with classic hemophilia.
    Kasper CK
    Thromb Diath Haemorrh; 1973 Nov; 30(2):263-71. PubMed ID: 4773365
    [No Abstract]   [Full Text] [Related]  

  • 19. Suggestions for the management of factor VIII inhibitors.
    Rubinger M; Rivard GE; Teitel J; Walker H;
    Haemophilia; 2000 Jul; 6 Suppl 1():52-9. PubMed ID: 10982269
    [No Abstract]   [Full Text] [Related]  

  • 20. Eloctate for hemophilia A.
    Med Lett Drugs Ther; 2015 Oct; 57(1479):143-4. PubMed ID: 26445206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.